Logo image
Durable Response to Larotrectinib in a Child With Histologic Diagnosis of Recurrent Disseminated Ependymoma Discovered to Harbor an NTRK2 Fusion: The Impact of Integrated Genomic Profiling
Journal article   Peer reviewed

Durable Response to Larotrectinib in a Child With Histologic Diagnosis of Recurrent Disseminated Ependymoma Discovered to Harbor an NTRK2 Fusion: The Impact of Integrated Genomic Profiling

Ross Mangum, Jacquelyn Reuther, Kelsey C Bertrand, Raghu Chandramohan, Marcia K Kukreja, Arnold C Paulino, Donna Muzny, Jianhong Hu, Richard A Gibbs, Daniel J Curry, …
JCO precision oncology, Vol.5(5), pp.1221-1227
2021
PMID: 34651095

Abstract

Brain Neoplasms - drug therapy Brain Neoplasms - genetics Brain Neoplasms - pathology Child Ependymoma - drug therapy Ependymoma - genetics Ependymoma - pathology Gene Expression Profiling Humans Male Membrane Glycoproteins - genetics Neoplasm Recurrence, Local Pyrazoles - therapeutic use Pyrazoles - urine Pyrimidines - therapeutic use Pyrimidines - urine Receptor, trkB - genetics
url
https://doi.org/10.1200/PO.20.00375View
Published (Version of record) Open

Metrics

1 Record Views

Details

Logo image